Trade Summary

3 days ago, Ecor1 Capital, LLC, serving as 10% owner at First Tracks Biotherapeutics, Inc. (TRAX), sold 4,705,575 shares at $13.81 per share, for a total transaction value of $64,999,990.00. Following this transaction, Ecor1 Capital, LLC now holds 3,174,519 shares of TRAX.

This sale represents a 60.00% decrease in Ecor1 Capital, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, April 20, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 22, 2026, 2 days after the trade was made.